The Los Angeles Post
California & Local U.S. World Business Lifestyle
Today: January 15, 2025
Today: January 15, 2025

Bristol-Myers Squibb to acquire Mirati in a $4.8 billion deal

Health
FILE PHOTO: Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration
April 26, 2024
Reuters - Reuters

(Reuters) - Bristol-Myers Squibb is set to acquire cancer drugmaker Mirati Therapeutics for $58 per share in cash, representing $4.8 billion equity value.

Bristol-Myers Squibb will finance the transaction with a combination of cash and debt.

The transaction is expected to be dilutive to Bristol-Myers Squibb's non-GAAP earnings per share by approximately 35 cents per share in the first 12 months after the transaction closes.

(Reporting by Dimpal Gulwani; Editing by Lisa Shumaker)

Related

Business|Economy|Political|Technology|US

Chip industry groups slam expected rules in private letter to Biden

A half-dozen trade groups from the semiconductor and manufacturing industries sent a private letter to U.S.

Chip industry groups slam expected rules in private letter to Biden
Business|Crime|Finance|Technology|US

SEC sues Elon Musk, saying he didn't disclose Twitter ownership on time before buying it

The U.S. Securities and Exchange Commission has sued billionaire Elon Musk, saying he failed to disclose his ownership of Twitter stock in a timely manner in early 2022, before buying the social media site

SEC sues Elon Musk, saying he didn't disclose Twitter ownership on time before buying it
Business|Economy|Europe|Finance|Political

UK stagflation risk adds pressure on Reeves after market volatility

British inflation figures will be closely watched on Wednesday as a sharp jump in government borrowing costs, concerns about domestic and global price pressures and

UK stagflation risk adds pressure on Reeves after market volatility
Americas|Business|Economy|Political

Canada clears $34 billion Bunge-Viterra merger with conditions

Canada on Tuesday approved with conditions U.S. grains merchant Bunge's $34 billion merger with Glencore-backed Viterra, clearing one of the final remaining

Canada clears $34 billion Bunge-Viterra merger with conditions
Share This

Popular

Business|Economy|Europe|Finance

Euro zone households could increase consumption, ECB chief economist says

Euro zone households could increase consumption, ECB chief economist says
Asia|Business|Economy|Finance|Political|Stock Markets

Foreigners sold South Korean equities last month by most since early 2020

Foreigners sold South Korean equities last month by most since early 2020
Business|Political|Technology|US

TikTok seeks to reassure U.S. employees ahead of Jan. 19 ban deadline

TikTok seeks to reassure U.S. employees ahead of Jan. 19 ban deadline
Asia|Business|Economy|Finance|Political

Japan likely to miss primary budget surplus target for FY2025, sources say

Japan likely to miss primary budget surplus target for FY2025, sources say